A new survey from the USC Schaeffer Center for Health Policy & Economics finds that a large majority of older adults would be interested in receiving a vaccine designed to significantly reduce the risk of dementia. The research suggests that, if such a vaccine became available, demand among this age group could be substantial.
The survey asked older adults about their willingness to take a dementia vaccine, without specifying a particular candidate or trial. The strong positive response indicates that the concept of vaccination for dementia prevention is broadly acceptable to the target population.
These findings are notable because they measure real-world receptiveness at a time when dementia vaccines remain experimental. While the survey does not evaluate any specific vaccine's efficacy or safety, it highlights a potential gap between scientific development and public readiness that could shape future rollout strategies.